IVDs are essential for disease detection, personalized treatment, and public health, driving growth in the global diagnostics ...
GENCURIX signs as inaugural partner to develop multiplex oncology assays for tissue and liquid biopsies Partnership aims to broaden adoption of QIAcuityDx Four platform offering clinical diagnostic ...
The new partnership combines QIAGEN’s QIAcuityDx digital PCR platform to advance sensitive, cost-effective oncology diagnostics with GENCURIX’s expertise in multiplex assay development. The aim is to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback